Otherwise, there were obviously more peripheral MDSCs and CD68+CD163+M2-like macrophages in NSCLC patients of the RT group than the pre-RT group (Figures 1(c) and 1(d)). This evidence concerns the gene CD163 and non-small cell lung carcinoma.